One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood-2018-99-116081
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 8 |
Affiliation: Manchester Academic Health Science Centre, University of Manchester, The Christie NHS Foundation Trust, Washington University in St. Louis, Medical College of Wisconsin, Humanitas University, University Hospitals of Cleveland, University College London, University of California, San Diego, Northside Hospital, Prisma Health, Emory University, Adc Therapeutics (Switzerland), Columbia University
Interim Results from the First-in-Human Clinical Trial of Adct-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
